References - EXERCISE

FEATURE REFERENCES

1. Dieterich D. Hepatitis C virus and HIV coinfection: A sleeping giant wakes. Medscape HIV/AIDS: Annual Update 2000. ©2000, Medscape, Inc. Accessed June 6, 2000 at: <http://www.medscape. com/medscape/HIV/TreatmentUpdate/2000/tu01/tu01-03.html>

2. KE Sherman and others. Hepatitis C prevalence in HIV-infected patients: A cross-sectional analysis of the US adult clinical trials group. Abstract and oral presentation 116. 10th International Symposium on Viral Hepatitis and Liver Disease. April 9-13, 2000. Atlanta, Georgia.

3. O'Brien WA. Hepatitis B and C virus coinfection with HIV. 7th Conference on Retroviruses and Opportunistic Infections. January 31, 2000. ©, Medscape Inc. Accessed on Medscape June 6, 2000, at: <http://www. medscape.com/medscape/cno/2000/retro/Story.cfm?story_id=1018>.

4. Harvey S. Bartnof, reporting on the Co-Infection Seminar for Physicians Held in San Francisco. Speakers: Afdhal NH. Current strategies for the diagnosis and treatment of hepatitis C. Innovations in the Management of Hepatitis C. March 3, 2000, San Francisco, California.

6. Hepatitis C virus (HCV) and HIV coinfection. J Intl Assoc Physicians in AIDS Care. 12th World AIDS Conference September, 1998.

7. CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV- related chronic disease. MMWR. 1998;47 (No. RR-19).

8. Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitus C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997;35:.

9. U.S. Public Health Service. HIV prevention bulletin: Medical advice for persons who inject illicit drugs. May 9, 1997. Rockville, Maryland: CDC, 1997.

10. Dove LM, et al, HCV quasispecies as a mechanism of rapidly progressive liver disease in patients infected with the human immunodeficiency virus. Abstract 1183 at the 50th Annual Meeting of the American Association for the Study of Liver Diseases. Dallas, Texas, November 5-9, 1999. Hepatology. 30(4)(Suppl 2):456A.

11. Sherman KE, et al. Quantitative evaluation of hepatitis C virus in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol. 1993;31(10);.

12. Bonacini M, et al., Patients coinfected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepatol. 1999;6(3):.

13. Youle M. Mangement issues for the millennium-and how we pay for them. 7th European Conference on Clinical Aspects and Treatment of HIV Infection, October 27, 1999. Conference Report. ©2000, Medscape. Accessed June 6, 2000 at : <http://www.medscape.commedscape/cno/1999/ECCAT/Story.cfm?story_id=857>

14. McGovern BH, et al. Increasing mortality from end-stage liver disease secondary to hepatitis C in patients with human immunodeficiency virus infection. Abstract and poster presentation 235 at the 37th Annual Meeting of the Infectious Diseases Society of America (IDSA). November 18-21, 1999, Philadelphia, Pennsylvania.

15. Gupta AK, et al. Increasing incidence of hepatitis C (HCV) and human immunodeficiency virus (HIV)-HCV co-infection: Significance for the future. Abstract and poster presentation 708 at the 37th Annual Meeting of the Infectious Diseases Society of America (IDSA), November 18-21, 1999, Philadelphia, Pa.

16. Selik RM, et al. Increases in the percentage of liver disease among deaths with HIV infection. Abstract and poster presentation F006 at the 10th International Symposium on Viral Hepatitis and Liver Disease, April 9-14, 2000, Atlanta, Ga.

17. Herrine SK. Controversial issues in HCV. American Asociation for the Study of Liver Diseases 50th Annual Meeting. Conference Report. ©1999, Medscape, Inc. Accessed June 6, 2000 at: <http://www.medscape.com/medscape/CNO/1999/AASLD/AASLD.10.html>.

18. From "Ask the Experts on... Antiretroviral Benefit From Interferon?" Reply provided by Jean-Michel Molina, MD, July 7, 2000. Accessed on July 12, 2000 at: <http://hiv.medscape.com/medscape/hiv/AskExperts/2000/07/AIDS-ae82.html.

close window